covid
Buscar en
Revista Internacional de Andrología
Toda la web
Inicio Revista Internacional de Andrología Carpolobia lutea roots restore sexual arousal and performance in paroxetine-indu...
Información de la revista
Vol. 12. Núm. 3.
Páginas 90-99 (julio - septiembre 2014)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
4529
Vol. 12. Núm. 3.
Páginas 90-99 (julio - septiembre 2014)
Original
Acceso a texto completo
Carpolobia lutea roots restore sexual arousal and performance in paroxetine-induced sexually impaired male rats
Visitas
4529
Musa Toyin Yakubu
Autor para correspondencia
, Rukayat Oluwatoyin Jimoh
Phytomedicine, Toxicology and Reproductive Biochemistry Research Laboratory, Department of Biochemistry, University of Ilorin, Ilorin, Nigeria
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Tablas (7)
Table 1. Secondary metabolite constituents of aqueous extract of Corpolobia lutea roots.
Table 2. Effects of paroxetine hydrochloride on the sexual behaviour parameters of male rats.
Table 3. Effects of aqueous extract of Carpolobia lutea root on mount and intromission frequencies of paroxetine-induced sexual dysfunction in male rats.
Table 4. Effects of aqueous extract of Carpolobia lutea root on ejaculation frequency and mount latency of paroxetine-induced sexual dysfunction in male rats.
Table 5. Effects of aqueous extract of Carpolobia lutea root on latencies of intromission and ejaculation of paroxetine-induced sexual dysfunction in male rats.
Table 6. Effect of aqueous extract of Carpolobia lutea roots on post ejaculation interval of paroxetine-induced sexual dysfunction in male rats.
Table 7. Effect of aqueous extract of Carpolobia lutea roots on serum hormone concentration of paroxetine-induced sexual dysfunction in male rats.
Mostrar másMostrar menos
Abstract
Objective

This study aimed at investigating the aphrodisiac effects of aqueous extract of Carpolobia lutea root at the doses of 47, 94 and 141mg/kg body weight in paroxetine-induced sexual dysfunction in male rats.

Materials and methods

Thirty sexually active male rats (148.20±3.22g) were assigned into six groups (A–F) of five animals each. Rats in group A received 0.5ml of distilled water once daily for 7 days while those in groups B, C, D, E and F which were induced with sexual dysfunction (oral administration of 10mg/kg of paroxetine suspension, once daily for 21 days) received 0.5ml corresponding to 7.14mg/kg body weight of PowmaxM, 47, 94 and 141mg/kg body weight of the extract and distilled water, respectively. Sexual behaviour parameters (frequencies of mount (ML), intromission (IF), ejaculation (EL), latencies of mount (ML), intromission (IL), ejaculation (EL) and post ejaculation interval (PEI)) were monitored 30min post administration by pairing (1:1) with receptive female rats (114.01±2.64g) on days 1, 4 and 7. The concentrations of serum testosterone, follicle stimulating hormone (FSH) and luteinizing hormone (LH) were determined after 7 days of administration using standard methods.

Results

The study revealed that the extract contained saponins (21.02mg/L), anthraquinones (5.11mg/L), alkaloids (2.93mg/L), flavonoids (1.82mg/L), tannins (0.91mg/L) and cardiac glycosides (0.09mg/L) whereas terpenes, phlobatannins and steroids were not detected. Paroxetine significantly (p<0.05) decreased mount frequency, intromission frequency, ejaculation frequency and ejaculation latency whereas it increased mount latency, intromission latency and post-ejaculatory interval for more than the baseline of 25% in each case. In contrast, all the doses of the extract significantly (p<0.05) attenuated the parameters of sexual behaviour displayed by the sexual dysfunction animals, with the 141mg/kg body weight comparing favourably (p>0.05) with the sexual dysfunction animals treated with Powmax. In addition, the extract significantly (p<0.05) elevated the levels of serum luteinizing hormone, follicle stimulating hormone and testosterone which were hitherto reduced by paroxetine.

Conclusion

The study concludes that the aqueous extract of C. lutea root especially the doses of 94 and 141mg/kg body weight restored various components of sexual arousal and performance as well as the reproductive hormones in the sexually sluggish male rats with the highest dose being the most effective. Present findings provide experimental evidence to support the folkloric claim of the plant in the management of sexual inadequacies in males.

Keywords:
Aphrodisiac
Carpolobia lutea
Paroxetine
Polygalaceae
Sexual dysfunction
Sexual function
Resumen
Objetivo

el objetivo del presente estudio fue investigar el efecto afrodisíaco del extracto acuoso de la raíz de Carpolobia lutea en dosis de 47, 94 y 141mg/kg de masa corporal para casos de disfunción sexual inducida por paroxetina en ratas macho.

Materiales y métodos

se distribuyeron treinta machos sexualmente activos (148,20±3,22g) en seis grupos (A-F) de 5 animales cada uno. Las ratas del grupo A recibieron 0,5ml de agua destilada al día durante 7 días, mientras que las de los grupos B, C, D, E y F—a quienes se había inducido una disfunción sexual con paroxetina (se administró una suspensión oral de paroxetina, 10mg/kg una vez al día durante 21 días)—recibieron respectivamente 0,5ml de PowmaxM en dosis de 7,14mg/kg de masa corporal, el extracto en dosis de 47, 94 y 141mg/kg de masa corporal, y agua destilada. Se observaron los parámetros de comportamiento sexual—frecuencia de cópula (ML), penetración (IF), eyaculación (EL), latencia de las cópulas (ML), penetración (IF), eyaculación (EL) e intervalo posteyaculación (PEI)—durante los 30 minutos subsiguientes a la administración comparando (1:1) con las ratas hembra (114,01±2,64g) en los días 1, 4 y 7. Las concentraciones de testosterona sérica, folitropina (FSH) y lutropina (LH) se fijaron con métodos normalizados después de 7 días de administración.

Resultados

el estudio reveló que el extracto contenía saponinas (21,02mg/l), antraquinonas (5,11mg/l), alcaloides (2,93mg/l), flavonoides (1,82mg/l), taninos (0,91mg/l) y glucósidos cardiacos (0,09mg/l), si bien no se detectaron terpenos, florotaninos ni esteroides. La paroxetina redujo de manera significativa (p<0,05) la frecuencia de cópula, frecuencia de penetración, frecuencia de eyaculación y latencia de las cópulas, aunque aumentó la latencia de las cópulas, latencia de penetración y el intervalo posteyaculación en más de un 25% respecto a los valores de referencia en casa caso. Por el contrario, todas las dosis del extracto atenuaron de manera significativa (p>0,05) el comportamiento sexual de los animales con la disfunción sexual; aquellos con 141mg/kg de masa corporal arrojaron resultados favorables (p>0,05) en comparación con los que fueron tratados con Powmax. Asimismo, el extracto aumentó enormemente (p<0,05) los niveles séricos de lutropina, folitropina y testosterona que hasta el momento se veían reducidos por la paroxetina.

Conclusión

el estudio llega a la conclusión de que el extracto acuoso de la raíz de C. lutea, con las dosis de 94 y 141mg/kg de masa corporal en particular, recuperaron varios componentes de la excitación y el rendimiento sexual, así como las hormonas reproductivas en las ratas macho sexualmente lentas. La dosis más alta resultó ser la más eficaz. Los presentes hallazgos suponen una demostración experimental para apoyar las reivindicaciones populares del uso de la planta en la gestión de incapacidades sexuales en varones.

Palabras clave:
Afrodisíaco
Carlopobia lutea
Paroxetina
Polygalaceae
Disfunción sexual
Función sexual
Texto completo
Introduction

Sexual relationships/interactions are among the most important social and biological activities in animals. Male sexual behaviour consists of both appetitive (motivational) and consummatory components that are regulated by gonadal steroid hormones secreted from the testes.1 Male sexuality is mainly governed by a well organized neural circuit that connects a variety of brain areas including the medial preoptic area, nuclear accumbens and the bed nucleus of stria terminals which appear to control the different components of mating behaviours.2,3 However, at one time or the other, this sexual relationship or sexuality may be bedevilled with some challenges such as sexual dysfunction. Sexual dysfunction in males (MSD) is the repeated inability to perform satisfactory sexual intercourse in 25% of all attempted sexual encounter. It also refers to hindrance/problems during any phase of the sexual response cycle that prevents individuals or couples from performing or enjoying normal sexual activity. MSD presents as erectile dysfunction or impotence (inability to have or maintain an erection sufficient for sexual functioning); ejaculation disorders including premature, inhibited, retarded or retrograde ejaculation; orgasmic disorder (inability to reach orgasm/climax with a partner, absence of orgasm during sexual intercourse and/or absence of orgasm without lengthy sexual contact), inhibited or hypoactive sexual desire (a disinterest in sexual contact or complete lack of sexual desire) and priapism (prolonged erection unaccompanied by sexual desire). Sexual dysfunctions are highly prevalent in men worldwide and Rosen4 puts it at 31% while Lewis et al.5 estimated it to be 20–30% and it increases with age. Several management options for MSD which included medications, mechanical aids such as penile implants, psychological and hormonal interventions are not without their shortcomings such as aching in the copulatory organ, urethral burning, infections, pains and bleeding.6 Therefore, there is the need to search for cheaper, effective options with reduced side effects in medicinal plants.

Carpolobia lutea G. Don (family: polygalaceae) is also known as cattle stick (English), ikpafum (Ibibio, Southern Nigeria), Agba or Angalagala (Igbo-Eastern Nigeria) and Oshunshun (Yoruba-Western Nigeria).7 It is widely found in tropical Africa where it grows in the rainforest and Guinea savannah of Sierra Leone and Cameroon as a dense overgrowth or an evergreen shrub or small tree of 5m high.8 Ethnobotanically, various parts of the plant have been claimed to be used in the management of several ailments. For instance, the leaves are used to cure fever, ulcer, malaria, dermal infection, venereal diseases, sterility, vermifuge, taenifuge, stomach problem, diarrhoea, headache, leprosy, snakebite and wounds. The leaves have also been used to promote child birth while the root bark have been implicated to be used for treating rheumatism, fever, general pain and insanity.9–13 The stem bark is dried and taken as snuff to cure migraine9. Furthermore, the decoction of the root is reputed in Western and Southern Nigeria (Yoruba ethnicity and Ibibios of Akwa Ibom State of Nigeria) as “ogun aleko” meaning sex invigorating tonic or aphrodisiac.12,14

Pharmacological studies reported in the open scientific literature on C. lutea are limited to anti-diarrhoeal and anti-ulcerogenic activities of the ethanolic extract and ethyl acetate fractions of the leaf,14,15 gastroprotective effect of the leaf extract,16 neuropharmacological activity of the cinnamoyl and coumaroyl glucosides from leaf fractions,17in vitro antiplasmodial,18 antimicrobial activity of the leaves,19in vivo antimalarial activity of the ethanolic extract and fractions of leaf and root,20 analgesic,21,22 contraceptive,23in vitro anti-trypanosomal and anti-leishmanial activities,24 antidiabetic and hypoglycaemic activities of ethanolic leaf extract and fractions.8

Although, myriads of scientific studies on the efficacy of the plant have been reported, there is no scientific report that has evaluated the sexual function enhancing effect of the plant, notwithstanding the acclaimed use of the plant as an aphrodisiac in some regions of Nigeria and Cote D’ Ivore. Therefore, the present study aimed at evaluating the aphrodisiac effect of the aqueous extract of C. lutea root in paroxetine-induced sexually impaired male rats.

Materials and methodsPlant materials

Fresh roots of C. lutea were purchased from herb sellers at a market (Oja tuntun) in Ilorin, Nigeria. The plant was authenticated at the Department of Plant Biology, University of Ilorin, Ilorin, Nigeria and a voucher specimen (UIH No. 030) was deposited at the Herbarium Unit of the Department.

Animals

Thirty healthy, in-bred, sexually active, male Wistar rats weighing (148.20±3.22)g and equal number of female rats (114.01±2.64g) were obtained from the Animal Holding Unit of the Department of Biochemistry, University of Ilorin, Ilorin, Nigeria. The animals were placed in their respective cages and housed in a well-ventilated Animal House under the following conditions: temperature: 22±3°C; 12:12h light and dark cycle; humidity: 45–50%).25

Assay kits

Assay kits for testosterone, luteinizing and follicle stimulating hormones were products of Monobind Inc., Lake Forest, USA. Progesterone and estradiol benzoate were from Ningbo Tisun Medic Biochemic Co. Ltd., Ningbo, Peoples Republic of China and Sigma Chemical, St. Louis, USA, respectively. All other reagents used were of analytical grade and were prepared in volumetric flask using all glass-distilled water.

Preparation of extract

The fresh roots of C. lutea were sliced very thinly, oven-dried at 40°C for 48h and pulverized. A known weight (50g) of the powder was extracted in 200ml of distilled water for 48h at room temperature with constant shaking. The lyophilized (Vir Tis Benchtop K, Vir Tis Co., Gardiner, NY) filtrate yielded 5.12g (percentage yield of 10.24%). Calculated amounts of the yield were constituted in distilled water to give the required doses of 47, 94, and 141mg/kg body weight. The dose of 94mg/kg body weight corresponded to what is normally used in the folk medicine by an adult male of 70kg for the management of sexual dysfunction while other doses of 47 and 141mg/kg body weight were half of 94mg/kg body weight and three fold of 47 mg/kg body weight.

Phytochemical screening

The extract of C. lutea roots was screened for the presence of some secondary metabolites as described for alkaloids, saponins, tannins, anthraquinones, cardiac glycosides, flavonoids, terpenes, phlobatannins and steroids.26 The amount of the detected metabolites was determined as described for saponins,27 anthraquinones and cardiac glycoside,28 alkaloids,29 flavonoids30 and tannins.31

Induction of sexual dysfunction and assessment of mating behaviour indices in male rats

Twenty-five male rats were orally administered 10mg/kg of paroxetine hydrochloride suspension (prepared daily in Tween-80 [BDH Chemicals Ltd., Poole, England], suspended in 0.9% saline solution) using a metal oropharyngeal cannula, once daily for 21 days to induce sexual dysfunction.32,33 Similarly, intact, healthy female rats were artificially brought into oestrus (since female rats allows indiscriminate mating only during this period and for the data to be reliable) by a single injection of 50μg of estradiol benzoate 36h before testing with male rats.32 Rats in the oestrus phase were confirmed by vaginal smears examinations as described by OECD.34 The primed female rats that exhibited profound receptivity were introduced into the cages containing the male rats after which the following sexual behaviour parameters were observed directly from the cage side and also using camera (Cannon PowerShot A560 Digital, Canon Inc., USA) in dim light, for 30min: MF (number of times the male assumes copulatory position but failed to achieve intromission-characterized by lifting of the males fore body over the hind quarter of the female and clasping her flanks with its fore hand); IF (number of intromissions from the time of introduction of the female until ejaculation); EF (number of ejaculations made during the observatory period); ML (time interval between the introduction of the female and the first mount by the male); IL (time interval from the introduction of the female to the first intromission by the male, usually characterized by pelvic thrusting and springing dismounts); EL (time interval between the first intromission and ejaculation, usually characterized by longer, deeper pelvic thrusting and slow dismount followed by a period of inactivity or reduced activity) and PEI (time interval between ejaculation and erection of the male copulatory organ for the next phase). The frequencies and latencies of these behaviour parameters were determined electronically from cassette transcription and were reconciled with camera recording. Male rats which showed minimum reduction of 25% in MF, IF, EF and EL as well as minimum increase of 25% in ML, IL and PEI were declared as having sexual dysfunction and used for the subsequent study.35

Animal grouping and extract administration

Thirty male rats, after two weeks of acclimatization were assigned into six groups (A–F) of five animals each. Rats in group A (control group) were orally administered 0.5ml of distilled water, once daily with the aid of a metal oropharnygeal cannula while those in groups B, C, D, E and F, apart from being induced with sexual dysfunction (10mg/kg of paroxetine suspension (prepared daily in Tween-80 [BDH Chemicals Ltd., Poole, England], suspended in 0.9% saline solution)32,33 also received 0.5ml each of distilled water, 7.14mg/kg body weight of PowmaxM (a reference male sexual stimulant and energy enhancer polyherbal drug consisting of Panax ginseng, Camelia sinensis, Cnidium monnier, Epimedium brevicornum, Songaria cynomorium, Gingko biloba, Dahurian angelica, Salvia miltiorrhiza root, l-arginine hydrochloride and Gamma aminobutyric acid), 47, 94 and 141mg/kg body weight of the extract respectively. Exactly 30min after treatment, the male rats were monitored for sexual behaviour on days 1, 4 and 7 as previously described. The study was conducted following the guidelines on the care and use of laboratory animals of the Ethical Committee of the Department of Biochemistry, University of Ilorin. The guidelines on the use of experimental animals by the European Convention and other Scientific purposes-ETS-123 were also strictly adhered to.36

Preparation of serum

The procedure described by Yakubu et al.37 was adopted for the preparation of serum. Twenty-four hours after seven daily doses of the distilled water, extract and PowmaxM to the animals, the rats were anaesthetized in diethyl ether fumes. When they became unconscious, the jugular veins were cut and 5ml of the blood was collected in centrifuge tubes, allowed to clot for 10min at room temperature and centrifuged at 685×g for 10min. The serum was collected with the aid of Pasteur pipette and used within 12h of preparation for the hormone analyses.

Determination of serum male reproductive hormones

The concentrations of testosterone, FSH and LH in the serum of the animals were determined according to the test procedures outlined in the Instruction Manual contained in the assay kits. Although the hormone assay kits were designed for use on human serum by a microplate immunoenzymometric assay (EMA/ELISA), the analyzer was calibrated and validated for use with animal sera. In the case of the testosterone, the within- and between-assay precision coefficients of variation were 4.1% and 7.3%, respectively, and the correlation coefficient, sensitivity of the assay, and cross-reactivity were 0.805, 0.445ng/mL, and 0.8, respectively. Furthermore, the within- and between-precision assay coefficients of variation for FSH were 3.5% and 7.0%, respectively whereas those for LH were 3.6% and 8.4% respectively. The correlation coefficient, sensitivity, and cross-reactivity for LH were 0.878, 0.003mIU/well, and <0.0001 while 0.908, 0.006mIU/well and <0.0001 were for FSH.

Statistical analysis

Data were expressed as the mean±SEM of five determinations except otherwise stated. The data were subjected to statistical analysis using Duncan's multiple range test and complemented with Students t-test. The analyses were done with Students Package for Social Science, version 17.0 (SPSS Inc.; Chicago, USA). Differences were considered statistically significant at p<0.05.

Results

Phytochemical screening of the aqueous extract of C. lutea root revealed the presence of saponins, anthraquinones, alkaloids, flavonoids, tannins and cardiac glycosides whereas terpenes, phlobatannins and steroids were not detected (Table 1). Saponins occurred as the most abundant in the root extract while glycosides and tannins were present in trace amount. In addition, alkaloids, anthraquinones and flavonoids were present in moderate amount (Table 1).

Table 1.

Secondary metabolite constituents of aqueous extract of Corpolobia lutea roots.

Secondary metabolite  Concentration (mg/L) 
Saponins  21.02±0.50 
Anthraquinones  5.11±0.005 
Alkaloids  2.93±0.005 
Flavonoids  1.82±0.01 
Tannins  0.91±0.002 
Cardiac glycosides  0.90±0.001 
Terpenes  Not detected 
Phlobatannins  Not detected 
Steroids  Not detected 

Values are means±three determination.

Treatment of the sexually active male rats with paraoxetine hydrochloride significantly reduced (p<0.05) the MF, IF, EF and EL and also increased the ML, IL and PEI; the change in each of the parameter was more than the baseline of 25% (Table 2).

Table 2.

Effects of paroxetine hydrochloride on the sexual behaviour parameters of male rats.

Parameters  Distilled water treated control  Paroxetine-treated animals  Percentage change (%) 
Mount frequency  21.60±1.47a  7.60±0.51b  64.81 
Intromission frequency  12.80±0.86a  4.20±0.37b  67.19 
Ejaculation frequency  1.60±0.40a  1.02±0.21b  36.25# 
Ejaculation latency (s)  122.60±1.33a  70.20±3.38b  42.74 
Mount latency (s)  48.40±1.12a  88.00±3.25b  81.82* 
Intromission latency (s)  84.60±1.33a  127.90±1.78b  51.18* 
Post-ejaculation interval (s)  150.80±1.77a  207.20±5.16b  37.40* 

Data are mean of five determinations±SEM.

Values carrying superscripts different from the control for each parameter are significantly different (p<0.05).

#

Means percentage decrease in parameter.

*

Means percentage increase in parameter.

The extract significantly and progressively increased the MF and IF in the paroxetine-induced sexually sluggish animals with the values of MF and IF that were not significantly different (p>0.05) from those of sexually impaired animals treated with the reference drug, PowmaxM (Table 3).

Table 3.

Effects of aqueous extract of Carpolobia lutea root on mount and intromission frequencies of paroxetine-induced sexual dysfunction in male rats.

  Mount frequencyIntromission frequency
Groups/days 
Distilled water (control)  19.40±0.40a  18.40±0.40a  20.20±0.20a  15.40±0.24a  15.40±0.51a  16.00±0.55a 
Sexual dysfunction+distilled water  8.25±0.63b  8.50±0.29b  8.00±0.82b  5.00±0.82b  6.00±0.41b  4.00±0.41b 
Sexual dysfunction+PowermaxM  16.33±0.33c  16.67±0.88c  16.67±0.82c  12.22±1.52c  14.33±0.3a  15.00±1.15a 
Sexual dysfunction+47mg/kg of extract  10.67±0.67bd  13.33±1.76d  12.00±0.57d  8.34±0.67d  10.66±0.66e  10.33±1.21e 
Sexual dysfunction+94mg/kg of extract  12.25±0.85cd  14.00±0.71d  16.75±0.48c  10.50±0.29e  11.00±0.58e  13.67±2.19c 
Sexual dysfunction+141mg/kg of extract  12.67±0.66cd  18.66±0.66 a  19.33±0.56a  9.33±0.67d  15.66±1.76a  15.67±2.19a 

Data are mean of five determinations±SEM.

Values carrying superscripts different from control from the control down the group for each day and parameter are significantly different (p<0.05).

Extract administration significantly (p<0.05) attenuated and increased the EF of the paroxetine-induced sexual dysfunction in the animals (Table 4). In contrast, the ML of the sexually impaired animals was reduced in a manner related to the doses and exposure periods (Table 4).

Table 4.

Effects of aqueous extract of Carpolobia lutea root on ejaculation frequency and mount latency of paroxetine-induced sexual dysfunction in male rats.

  Ejaculation frequencyMount latency (s)
Groups/days 
Distilled water (control)  3.60±0.40a  3.40±0.50a  3.20±0.39a  42.80±1.21a  44.00±2.82a  43.20±1.85a 
Sexual dysfunction+distilled water  0.25±0.02b  0.25±0.01b  0.22±0.02b  100.70±1.25b  102.0±4.24b  108.25±3.42b 
Sexual dysfunction+PowermaxM  2.67±0.33c  2.67±0.33c  3.00±0.0a  72.67±1.33c  47.33±0.84a  44.00±0.58a 
Sexual dysfunction+47mg/kg of extract  1.33±0.33d  1.33±0.33d  1.67±0.33d  40.67±0.88a  33.66±2.33d  31.67±3.28d 
Sexual dysfunction+94mg/kg of extract  2.50±0.28c  2.55±0.47c  2.70±0.09c  29.50±3.57e  24.75±4.31e  14.25±1.93f 
Sexual dysfunction+141mg/kg of extract  3.67±0.13a  3.67±0.33a  3.84±0.33e  15.00±0.53f  10.00±0.31g  10.00±0.58g 

Data are mean of five determinations±SEM.

Values carrying superscripts different from control from the control down the group for each day and parameter are significantly different (p<0.05).

In addition, all the doses of the extract significantly decreased (p<0.05) the IL of the sexually sluggish animals whereas the EL was significantly prolonged (p<0.05) (Table 5). The alterations in the IL and EL by the extract did not compare favourably (p>0.05) with the non-sexually impaired animals treated with distilled water (Table 5).

Table 5.

Effects of aqueous extract of Carpolobia lutea root on latencies of intromission and ejaculation of paroxetine-induced sexual dysfunction in male rats.

  Intromission latency (s)Ejaculation latency (s)
Groups/days 
Distilled water (control)  89.60±1.29a  87.70±4.02a  88.60±3.29a  45.20±2.32a  44.0±3.46a  49.60±1.44a 
Sexual dysfunction+distilled water  133.25±1.11b  159.0±1.81c  174.75±1.81d  7.50±0.21b  7.75±0.90b  6.00±0.91b 
Sexual dysfunction+PowermaxM  82.33±6.06e  54.00±1.15f  35.67±3.18g  62.0±3.46c  63.33±2.91c  59.67±0.66c 
Sexual dysfunction+47mg/kg of extract  62.00±2.31h  68.53±3.29h  61.33±0.66h  79.0±0.58d  82.67±2.67d  76.33±0.88d 
Sexual dysfunction+94mg/kg of extract  33.75±2.84g  26.25±3.04gi  21.25±3.52i  74.25±0.65ed  95.25±1.89f  102.25±1.65f 
Sexual dysfunction+141mg/kg of extract  20.00±1.15i  15.00±1.15j  12.61±1.21j  100.67±2.19f  130.66±1.2g  164.33±3.84h 

Data are mean of five determinations±SEM.

Values carrying superscripts different from control from the control down the group for each day and parameter are significantly different (p<0.05).

The computed post-ejaculatory interval of the sexual dysfunction male rats was decreased (p<0.05) following the administration of the extract in a manner related to the doses and the exposure periods (Table 6).

Table 6.

Effect of aqueous extract of Carpolobia lutea roots on post ejaculation interval of paroxetine-induced sexual dysfunction in male rats.

Groups  Post ejaculatory interval (s)
  Day 1  Day 4  Day 7 
Distilled water (control)  145.0±2.08a  140.67±1.20a  142.33±0.89a 
Sexual dysfunction+distilled water  189.00±0.58b  181.67±1.20b  185.00±0.58b 
Sexual dysfunction+PowermaxM  164.33±0.88c  142.33±0.33a  139.00±0.88a 
Sexual dysfunction+47mg/kg of extract  142.00±4.04a  145.67±4.70a  142.33±1.78a 
Sexual dysfunction+94mg/kg of extract  102.00±3.21d  96.67±1.20d  95.67±2.02d 
Sexual dysfunction+141mg/kg of extract  78.67±0.33e  61.00±1.00ef  47.67±0.88g 

Data are mean of five determinations±SEM. Values carrying superscripts different from control from the control down the group for each day and parameter are significantly different (p<0.05).

All the doses of the extract significantly elevated the levels of testosterone, FSH and LH in the serum of the sexual dysfunction animals when compared with the paroxetine-induced sexually dysfunction animals (Table 7). The most profound increase in the serum testosterone which was higher than the non-dysfunction distilled water treated animals was obtained with the 141mg/kg body weight of the extract (Table 7). Unlike the testosterone, the elevated levels of FSH and LH in the serum of the animals were not significantly different from those of the non-sexually impaired distilled water treated animals (Table 7).

Table 7.

Effect of aqueous extract of Carpolobia lutea roots on serum hormone concentration of paroxetine-induced sexual dysfunction in male rats.

Treatments  Testosterone (nmol/L)  Follicle stimulating hormone (mlU/mL)  Luteinizing hormone (mlU/mL) 
Distilled water (control)  8.00±0.05a  0.43±0.08a  3.64±0.21a 
Sexual dysfunction+distilled water  2.37±0.17b  0.15±0.05b  1.60±0.34b 
Sexual dysfunction+PowermaxM  4.14±0.13c  0.06±0.01c  2.17±0.02c 
Sexual dysfunction+47mg/kg of extract  5.63±0.24d  0.12±0.02b  2.49±0.09cd 
Sexual dysfunction+94mg/kg of extract  6.39±0.24d  0.23±0.01d  2.90±0.25e 
Sexual dysfunction+141mg/kg of extract  9.57±0.48e  0.53±0.49a  3.55±0.43a 

Data are mean of five determinations±SEM. Values carrying superscripts different from control from the control down the group for each day and parameter are significantly different (p<0.05).

Discussion

Several substances of plant and animal origin which have been used in many cultures of the developed and developing countries as aphrodisiacs are yet to be substantiated or refuted with scientific data/evidence. To understand the scientific basis/rationale behind the acclaimed use of C. lutea root as an enhancer of libido, potency and sexual pleasure, this study was evaluated in sexually deficient rat model.

Induction of sexual dysfunction in rats by paroxetine hydrochloride has been described as a useful experimental model to study sexual dysfunction in male animals33,35 and is gaining wide acceptance. Paroxetine, used for the management of depression and anxiety is a selective-serotonin reuptake inhibitor that delays or abolishes orgasm or libido by inhibiting the activity of nitric oxide synthase. Systemic inhibition of nitric oxide synthase impairs copulation and decrease penile erection in rats.38 The production of nitric oxide catalyzed by nitric oxide synthase facilitates sexual behaviour possibly by mediating the release of neurotransmitter and galvanizing genomic changes and protein synthesis or some combination thereof in the medial preoptic area of male rats.39 Paroxetine manifest its effects on sexual function by delaying orgasm/sex drive, copulating and ejaculatory behaviours (difficulties in maintaining an erection and inhibiting ejaculations).33 It also substantially decreases the concentration of testosterone in male animals. Therefore, the reduction in MF, IF, EF and EL as well as prolonged ML, IL, and PEI following the administration of paroxetine in the present study confirmed that sexual activity in the male rats has been abolished/impaired, suggesting a model of sexual dysfunction in rats. Paroxetine might have induced sexual dysfunction in the animals through any or all of the aforementioned mechanisms. The findings with respect to induction of sexual dysfunction in male rats by paroxetine in the present study are similar to those previously reported by Malviya et al.33 and Yakubu and Nurudeen.35

MF and IF are useful indices of vigour, libido and potency. An increase in MF reflects enhanced sexual motivation while a similar increase in the IF indicates efficiency of erection, penile orientation and the ease of activation of ejaculatory reflexes.40 Furthermore, increase in EF gives an idea of the number of successful expulsion of semen into the vagina of the female rats. Therefore, the significantly and progressive increases in the MF and IF as well as the increased EF in the paroxetine induced sexually impaired animals by the extract in this study suggest that the extract has restored sexual competence in the sexually impaired male rats. The restoration of sexual function in the paroxetine-induced sexual dysfunction was similar to that of the reference drug, a polyherbal Powmax. The restoration of sexual function was evidenced in the enhanced anogenital sniffing and licking of the vaginal of the female by the male rats. The display of ear-wiggling, darting, hopping and lordosis by the oestradiol benzoate treated female rats in this study implied that oestrus was induced in the animals which culminated into behaviours of proceptivity and receptivity.

Mount and intromission latencies which are inversely proportional to sexual motivation can also be used to assess enhancement of sexual motivation and sexual appetitive behaviour in animals.40 The progressive reduction in the ML and IL suggests enhanced sexual appetitive behaviour. The stimulation of intromission and ejaculation were evident from the profound pelvic thrusting in the extract treated male animals during the observation period. The reduction in mount latency may also connote increased orientation activities towards the receptive females and restricted movement to a particular area of the cage where the female was. Decrease in ML also implies increase in sexual urge that is controlled by CNS mediated action. Furthermore, the prolonged EL suggests that the extract promoted coitus for sufficiently desired time. Such a delay in EL accompanied by sustained penile erection suggests involvement of nitric oxide in the whole process of sexual behaviour and performance.41 Again, the prolonged EL suggests that the extract could assist sexual dysfunction rats in controlling the timing of ejaculation through the modulation of serotonin and its receptors.

PEI is a widely acceptable index of potency, libido and rate of recovery from exhaustion after first series of mating.42 The significant reduction in the PEI by the extract indicates significant and sustained increase in sexual activity. The reduction in PEI by the extract suggests enhanced libido and potency, as well as increased copulatory efficiency of the male rats after treatment with the extract. All these are indications of sexual function/performance improving effects of the extract. The restoration of sexual activity by the extract in the paroxetine-induced sexual dysfunction in male rats by the extract in the present study is similar to the findings earlier reported by Malviya et al.33 and Yakubu and Nurudeen35 following the administration of alcoholic extract of Allium sativa bulbs and Cnestis ferruginea roots respectively. The extract has therefore restored sexual arousal, the state of sexual excitement or desire during the period of sexual interaction.

Experimental studies using plant extracts such as Tribulus terrestris and Fadogia agrestis have revealed that an increase in sexual function in rats could be attributed to a corresponding increase in testosterone, dihydrotestosterone and dehydroepiandrosterone contents of the animals.43–45 Clinical study has also demonstrated that T. terrestris extract increased body's natural testosterone levels, improved male sexual performance and build muscle.46 Therefore, the restored/enhanced sexual arousal and performance by the aqueous extract of C. lutea roots in the present study may not be unconnected with the increase in testosterone content of the sexual dysfunction animals. Aphrodisiacs, at the level of the central nervous system, act by altering specific neurotransmitter or increasing the level of sex hormone concentration, testosterone, in this instance. Thus, the improved serum testosterone level after administration of C. lutea extracts could be considered as one of the contributing factors responsible for an overall increase of sexual performance in the extract treated animals. The enhanced levels of testosterone after treatment with the extract could be foreseen as a possibility for using the herb in the restoration of sexual function in the sexually deficient rats. The modulation of testosterone, attributed to the presence of saponins is suggested to be mediated through its metabolic conversion into dehydroepiandrosterone.47 Besides central effects, testosterone has been shown to act peripherally by facilitating the nitrergic neurotransmission, accentuating nitric oxide synthase activity and releasing nitric oxide in the cavernosa, all of which contribute to penile erection48,49 that preceded intromission.

A concern that arises with sustained elevation in testosterone levels is the feedback inhibition of gonadotropin release.50 Although at this moment, it is not clear why the increase in testosterone content of the extract treated sexually impaired male rats was accompanied by similar elevated levels of the gonadotropins; the absence of this feedback inhibition in the present study could be due to LH and FSH secretory and/or releasing property. This proposition will have to await further studies.

The main components of C. lutea roots included saponins, alkaloids and flavonoids which have been implicated as agents that can facilitate sexual behaviours in animals. For instance, saponins act centrally to stimulate endogenous testosterone levels by acting as intermediate in steroidal pathway of androgen production and raising the levels of LH.44,51–53 In addition, the elevation in the androgen content by the saponins may in turn increase nitric oxide levels in penile tissues by modulating nitric oxide synthase isoenzymes. The nitric oxide then relaxes the corpus cavernosum smooth muscle by increasing guanosine monophosphate levels.54,55 Alkaloids on the other hand may act both peripherally and centrally to relax corpus cavernosum smooth muscle in the male rat copulatory organ or increase the release of nitric oxide from endothelia and nerve endings that induce vasodilation of blood vessels in sexual organ of male rats which eventually results in erection,56 a prerequisite for successful intromission. Flavonoids have been reported to increase mRNA and protein expression of neuronal nitric oxide synthase and inducible nitric oxide synthase as well as inhibit phosphodiesterase (PDE) types 5 and 6 and cyclic adenosine monophosphate specific PDE.57,58 Since saponins, alkaloids and flavonoids were found in the aqueous extract of C. lutea roots, the pro-sexual effects of the extract may be attributed to these secondary metabolites which might have acted either centrally and/or peripherally as well as singly and or in combination. Therefore, the use of the extract might be helpful in restoring sexual dysfunction. Further studies are, however, needed to clarify the specific role(s) of these metabolites in facilitating and/or restoring sexual dysfunction in the animals.

The present study concludes that the aqueous extract of C. lutea roots has restored androgen dependent sexual performance in sexually deficient male rats. The effects of the plant as an aphrodisiac were exerted on both the mechanism of sexual arousal and performance. The results, therefore, corroborate the hype of the plant as herbal cure for sexual dysfunction. The seemingly involvement of alkaloids, flavonoids and saponins from C. lutea roots and their mechanism of action as aphrodisiac will have to await the outcome of further studies.

Conflict of interest

The authors declare no conflict of interest.

References
[1]
E.M. Hull, R.I. Wood, K. McKenna.
The neurobiology of male sexual behavior.
3rd ed., pp. 1729-1842
[2]
E.M. Hull, J.M. Dominguez.
Getting his act together: roles of glutamate, nitric oxide, and dopamine in the medial preoptic area.
Brain Res, 1126 (2006), pp. 66-75
[3]
E.M. Hull, J.M. Dominguez.
Sexual behavior in male rodents.
Hormones Behav, 52 (2007), pp. 45-55
[4]
R.C. Rosen.
Prevalence and risk factors of sexual dysfunction in men and women.
Curr Psychiatry Rep, 2 (2000), pp. 189-195
[5]
R.W. Lewis, K.S. Fugl-Meyer, R. Bosch, A.R. Fugl-Meyer, E.O. Laumann, E. Lizza, et al.
Epidemiology/risk factors of sexual dysfunction.
[6]
M.T. Yakubu, M.A. Akanji, A.T. Oladiji.
Male sexual dysfunction and methods used in assessing medicinal plants with aphrodisiac potentials.
Phcog Rev, 1 (2007), pp. 39-46
[7]
I. Etukudo.
Ethnobotany: conventional and traditional uses of plants.
The Verdict Press, (2003),
[8]
M.M. Akpan, J.E. Okokon, J.E. Akpan.
Antidiabetic and hypolipidemic activities of ethanolic leaf extract and fractions of Carpolobia lutea.
Mol Clin Pharmacol, 3 (2012), pp. 100-107
[9]
F.R. Irvine.
Woody plants of Ghana, with special references to their uses.
Oxford University Press, (1961),
[10]
W.H. Lewis, M.P. Elvin-Lewis.
Medical botany.
John Wiley and Sons, (1977),
[11]
H.M. Burkill.
2nd ed., Royal Botanic Garden, (1985),
[12]
K.K. Ajibesin, B.A. Ekpo, D.N. Bala, E.E. Essien, S.A. Adesanya.
Ethnobotanical survey of Akwa Ibom State of Nigeria.
J Ethnopharmacol, 115 (2008), pp. 387-408
[13]
C.A. Muanya, O.A. Odukoya.
Lipid peroxidation as index of activity in aphrodisiac herbs.
J Plant Sci, 3 (2008), pp. 92-98
[14]
P.A. Nwafor, A.I. Bassey.
Evaluation of the antidiahorreal and antiulcerogenic potential of ethanol extract of Carpolobia lutea leaves in rodents.
J Ethnopharmacol, 111 (2007), pp. 619-624
[15]
L.L. Nwidu, P.A. Nwafor, W. Vilegas.
Antiulcer effects of ethyl acetate fraction of Carpolobia lutea leaf.
J Appl Pharmaceut Sci, 2 (2012), pp. 233-242
[16]
L.L. Nwidu, P.A. Nwafor.
Gastroprotective effects of leaf extracts of Carpolobia lutea (polygalaceae) G. Don. in rats.
Afr J Biotechnol, 8 (2009), pp. 15-19
[17]
L.L. Nwidu, P.A. Nwafor, W. Vilegas.
Neuropharmacological screening and isolation of cinnamoyl and coumaroylglucosides from leaf fraction of Carpolobia lutea G. Don (Polygalaceae).
Indian J Novel Drug Deliv, 4 (2012), pp. 28-37
[18]
J. Bero, H. Ganfon, M. Jonville, M. Frederich, F. Gbaguidi, P. DeMol, et al.
In vitro antiplasmodial activity of plants used in Benin in traditional medicine to treat malaria.
J Ethnopharmacol, 122 (2009), pp. 439-444
[19]
E. Ettebong, P.A. Nwafor.
In vitro antimicrobial activity of ethanolic root extract of Carpolobia lutea.
Pak J Pharm Sci, 22 (2009), pp. 335-338
[20]
J.E. Okokon, I.A. Effiong, E. Effiong.
In vivo antimalarial activities of ethanolic crude extracts and fractions of leaf and root of Carpolobia lutea.
Pak J Pharm Sci, 24 (2011), pp. 57-61
[21]
L.L. Nwidu, P.A. Nwafor, V.C. da Silva, C.M. Rodrigues, L.C. dos Santos, W. Vilegas, et al.
Anti-nociceptive effects of Carpolobia lutea G. Don (Polygalaceae) leaf fractions in animal models.
Inflammopharmacol, 19 (2011), pp. 215-225
[22]
C. Jackson, H. Mbagwu, I. Jackson, G. Ekpe, F. Etienam.
Analgesic activities of ethanolic extract of the root of Carpolobia lutea.
Afr J Pharm Pharmacol, 5 (2011), pp. 367-370
[23]
E.O. Ettebong, P.A. Nwafor, M. Ekpo, K.K. Ajibesin.
Contraceptive, estrogenic and antiestrogenic potentials of methanolic root extract of Carpolobia lutea in rodents.
Pak J Pharm Sci, 24 (2011), pp. 445-449
[24]
J. Bero, V. Hannaert, G. Chataigné, M.F. Hérent, J. Quetin-Leclercq.
In vitro antitrypanosomal and antileishmanial activity of plants used in Benin in traditional medicine and bio-guided fractionation of the most active extract.
J Ethnopharmacol, 137 (2011), pp. 998-1002
[25]
Organization for Economic Co-operation and Development. Guidance notes for analysis and evaluation of chronic toxicity and carcinogenicity studies. (OECD) Guidelines for the testing of chemicals: series on testing and assessment, no. 35). Final consultation's proposal. Retrieved August 8, from http://www.oils.oecd.org/oils/2002doc.nsf/LinkTo/env-jm mono (2002) 19.
[26]
S.R. Thimmaiah.
Standard methods of biochemical analysis.
2nd ed., Kaylon Press, (2004),
[27]
J.H. Brunner.
Direct spectrophotometric determination of saponins.
Anal Chem, 34 (1984), pp. 1314-1326
[28]
M.M. El-Olemy, F.J. Al-Muhtadi, A.A. Afifi.
Experimental phytochemistry. A laboratory manual.
King Saud University Press, (1994),
[29]
H.O. Edeoga, D.E. Okwu, B.O. Mbaebie.
Phytochemical constituents of some Nigerian medicinal plants.
Afr J Biotechnol, 4 (2005), pp. 685-688
[30]
B.O. Obadoni, P.O. Ochuko.
Phytochemical studies and comparative efficacy of the crude extracts of some homeostatic plants in Edo and Delta States of Nigeria.
Global J Pure Appl Sci, 8 (2001), pp. 203-208
[31]
T.P. Van-Burden, W.C. Robinson.
Formation of complexes between protein and tannic acid.
J Agric Food Chem, 1 (1981), pp. 77
[32]
J.S.W. Chan, M.D. Waldingger, B. Oliver, R.S. Oosting.
Drug-induced sexual dysfunction in rats.
Curr Protocol Neurosci, 9 (2010), pp. 9-34
[33]
N. Malviya, S. Jain, V.B. Gupta, S. Vyas.
Effect of garlic bulb on paroxetine-induced sexual dysfunction in male rats.
Asian J Pharm Biol Res, 1 (2011), pp. 218-221
[34]
Organization for Economic Co-operation and Development. Guidance or genetic document histological evaluation of endocrine and reproductive tests in rodents. Preparation, reading and reporting of vaginal smears; 2009.
[35]
M.T. Yakubu, Q.O. Nurudeen.
Effects of aqueous extract of Cnestis ferruginea (Vahl ex De Cantolle) root on paroxetine-induced sexual dysfunction in male rats.
Asian Pac J Reprod, 1 (2012), pp. 111-116
[36]
ETS. Council for Europe.
European convention for the protection of vertebrate animals used for experimental and other scientific purposes.
European Treaty Series, (2005),
[37]
M.T. Yakubu, A.T. Oladiji, M.A. Akanji.
Mode of cellular toxicity of aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem in male rat liver and kidney.
Hum Exp Toxicol, 28 (2009), pp. 469-478
[38]
E.M. Hull, L.A. Lumley, J. Matuszewich, J. Dominguez, J. Moses, D.S. Lorrain.
The roles of nitric oxide in sexual function of male rats.
Neuropharmacology, 33 (1994), pp. 1499-1504
[39]
J.M. Dominguez, J.H. Brann, M. Gil, E.M. Hull.
Sexual experience increases nitric oxide synthase in the medial preoptic area of male rats.
Behav Neurosci, 120 (2006), pp. 1389-1394
[40]
M.T. Yakubu, M.A. Akanji.
Effect of aqueous extract of Massularia acuminata stem on sexual behaviour of male Wistar rats.
Evid-Based Compl Altern Med, (2011), pp. 10
[41]
J. Du, E.M. Hull.
Effects of testosterone on neuronal nitric oxide synthase and tyrosine hydroxylase.
Brain Res, 836 (1999), pp. 90-98
[42]
A.S. Tajuddin, A. Latif, I.A. Qasmi.
Effect of 50% ethanolic extract of Syzygium aromaticum (L.) Merr. & Perry. (Clove) on sexual behaviour of normal male rats.
BMC Complement Altern Med, 4 (2004), pp. 17-24
[43]
K. Gauthaman, P.G. Adaikan, R.N.V. Prasda.
Aphrodisiac properties of Tribulus terrestis extract (protodioscin) in normal and castrated rats.
Life Sci, 71 (2002), pp. 1385-1396
[44]
M.T. Yakubu, M.A. Akanji, A.T. Oladiji.
Aphrodisiac potentials of the aqueous extract of Fadogia agrestis (Schweinf ex Hiern) stem in male albino rats.
Asian J Androl, 7 (2005), pp. 399-404
[45]
K. Gauthaman, P.G. Adaikan.
The hormonal effects of Tribulus terrestris and its role in the management of male erectile dysfunction-an evaluation using primates, rabbits and rats.
Phytomed, 15 (2008), pp. 44-54
[46]
G.A. Brown, M.D. Vukovich, T.A. Reifenrath, K.A. Parsons, R.L. Sharp, D.S. King.
Effects of anabolic precursors on serum testosterone concentration and adaptations to resistance training in young men.
Int J Sport Nutr Exerc Metab, 10 (2000), pp. 340-359
[47]
S.S. du Plessis, P.S. de Jongh, D.R. Franken.
Effect of acute in vivo sildenafil citrate and in vitro 8-bromo-cGMP treatments on semen parameters and sperm function.
Fertil Steril, 81 (2004), pp. 1026-1033
[48]
A. Aversa, F. Mazzilli, T. Rossi, M. Delfino, A.M. Isidori, A. Fabbri.
Effects of sildenafil (Viagra) administration on seminal parameters and post ejaculatory refractory time in normal males.
Hum Reprod, 15 (2000), pp. 131-134
[49]
L. Lefievre, E. De Lamirande, C. Gagnon.
The cyclic GMP-specific phosphodiesterase inhibitor, sildenafil, stimulates human sperm motility and capacitation but not acrosome reaction.
J Androl, 21 (2000), pp. 929-937
[50]
A.M. Matsumoto.
Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
J Clin Endocrinol Metab, 70 (1990), pp. 282-287
[51]
P.K. Suresh, A. Subramoniam, P. Pushpangadan.
Aphrodisiac activity of Vanda tessellata (Roxb.) Hook. ex Don extract in male mice.
Indian J Pharmacol, 32 (2000), pp. 300-304
[52]
M.T. Yakubu, M.A. Akanji, A.T. Oladiji, A.A. Adesokan.
Androgenic potentials of aqueous extract of Massularia acuminata (G. Don) Bullock ex Hoyl. stem in male Wistar rats.
J Ethnopharmacol, 118 (2008), pp. 508-513
[53]
A. Abedi, M. Parviz, S.M. Karimian, H.R.S. Rodsari.
Aphrodisiac activity of aqueous extract of Phoenix dactylifera pollen in male rats.
Adv Sex Med, 3 (2013), pp. 28-34
[54]
H.J. Kim, D.S. Woo, G. Lee, J.J. Kim.
The relaxation effects of ginseng saponin in rabbit corporal smooth muscle: is it a nitric oxide donor?.
Br J Urol, 82 (1998), pp. 744-748
[55]
R. Marin, A. Escrig, P. Abreu, M. Mas.
Androgen dependent nitric oxide release in rat penis correlates with levels of constitutive nitric oxide synthase isoenzymes.
Biol Reprod, 61 (1999), pp. 1012-1016
[56]
M.R. Zarrindast, K. Nojoomi, M. Sharifzadeh, A. Mokri.
Nitric oxide agents and apomorphine-induced rat behaviors.
Pharmacology, 71 (2003), pp. 169-173
[57]
W.J. Liu, Z.C. Xin, H. Xin, Y.M. Yuan, L. Tian, Y.L. Guo.
Effects of icariin on erectile function and expression of nitric oxide synthase isoforms in castrated rats.
Asian J Androl, 7 (2005), pp. 381-388
[58]
M. Dell’Agli, G.V. Galli, E.D. Cero, F. Belluti, R. Matera, E. Zironi, et al.
Potent inhibition of human phosphodiesterase-5 by icariin derivatives.
J Nat Prod, 71 (2008), pp. 1513-1517
Copyright © 2014. Asociación Española de Andrología, Medicina Sexual y Reproductiva
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.androl.2023.100369
No mostrar más